QleanAir wins an order from a US health system for a large Cleanroom project in a large home infusion center

2022-08-25

QleanAir AB (publ), the premium provider of solutions for clean indoor air, announces receiving an order worth 1.1 MUSD from a major health system to provide a USP 797 and USP 800 compliant cleanroom.

This cleanroom will be built in a new home infusion center at a major health system in the US, completion expected within Q3 2023. This order is the result of one of the letters of intent that were communicated August 1st 2022.

“We are pleased to grow our relationship with hospital compounding pharmacies and to significantly grow our business in the US. This is one more step towards making QleanAir a reliable and high-quality provider of clean spaces in the US”, says Zachary Douglas, President of QleanAir Scandinavia Inc.

About QleanAir

QleanAir is a niche premium provider of clean indoor environment solutions. The company’s business model is based on lease contracts for modular solutions with a full-service offer. QleanAir solutions are developed using filter technology that traps, filters and recycles indoor air. The company has over 11,000 installed units at more than 3,000 customers on the markets for EMEA, APAC and the Americas. For full year 2021, net sales amounted to 450 MSEK and adjusted operating margin was 18.5 percent. QleanAir’s head office is in Solna in Sweden, and the share is traded on Nasdaq First North Premier Growth Market, ticker QAIR. FNCA Sweden is Certified Adviser +46 8 528 00 399. For more information go to qleanair.com.

QleanAir wins an order from a US health system for a large Cleanroom project in a large home infusion center

QleanAir wins an order from a US health system for a large Cleanroom project in a large home infusion center

Share This Story, Choose Your Platform!